Latest news
Why Travere Therapeutics (TVTX) Is Up 9.0% After FILSPARI-Driven Q2 Revenue Jump And Wider Loss - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 07:11:19 GMTTVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney Drug Filspari - StocktwitsStocktwits · Fri, 07 Aug 2026 04:36:10 GMTTravere Therapeutics (TVTX) On Q2 Results And FILSPARI Hopes As Fair Value Stays In View - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 04:29:00 GMTDoes FILSPARI-Driven Revenue Growth And Wider Losses Change The Bull Case For Travere Therapeutics (TVTX)? - webull.comwebull.com · Thu, 06 Aug 2026 17:56:19 GMTTravere Therapeutics (TVTX) Stock Climbs On FILSPARI Momentum As Losses Deepen - simplywall.stsimplywall.st · Thu, 06 Aug 2026 13:23:33 GMTTravere Therapeutics Inc (TVTX) (Q2 2026) Earnings Call Highlights: Record FILSPARI Demand and ... - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 05:05:00 GMTTravere Therapeutics Reports Second Quarter 2026 Financial Results - BioSpaceBioSpace · Wed, 05 Aug 2026 02:46:54 GMTTVTX: FILSPARI's record Q2 sales and rapid FSGS launch drive strong growth and future confidence - TradingViewTradingView · Tue, 04 Aug 2026 23:17:05 GMT